methylazoxymethanol acetate has been researched along with Depression, Involutional in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babinska, Z; Carlo Altamura, A; Cremaschi, L; D'Addario, C; Dell'Osso, B; Di Bartolomeo, M; Drago, F; Maccarrone, M; Micale, V; Palazzo, M; Pucci, M; Stark, T; Sulcova, A | 1 |
1 other study(ies) available for methylazoxymethanol acetate and Depression, Involutional
| Article | Year |
|---|---|
A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia.
Topics: Animals; Bipolar Disorder; Cohort Studies; CpG Islands; Depressive Disorder, Major; Disease Models, Animal; DNA Methylation; Endocannabinoids; Female; Gene Expression Regulation; Humans; Leukocytes, Mononuclear; Male; Methylazoxymethanol Acetate; Middle Aged; Prefrontal Cortex; Promoter Regions, Genetic; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Schizophrenia | 2017 |